All News

Some urology practices may be contemplating delivering chronic care management services to eligible patients, and this article will answer key questions about the program and features to consider when making that decision.

This article provides an overview of the new 2018 ICD-10-CM codes, revisions, and deletions that are relevant to urology practice.

There are several options for saving for retirement, but first develop a good understanding of how these retirement accounts work to get the most out of your savings.

Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.

The proposed rule for MACRA and the Merit-based Incentive Payment System program was released June 21, 2017-- As expected, the program requiring the implementation of the new MIPS scoring system and incentives to move to alternative payment models will continue.

The chances of needing long-term disability insurance are higher than you might think and can be worth the expense

Other products discussed include cancer tests, an app to connect patients with specialists, a revenue management system, and more

Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.

As some assets appreciate in value and others lose value, your portfolio’s allocation changes. Rebalancing is the remedy for asset drift and an important part of maintaining a healthy investment portfolio.

The practical application of medical necessity has taken many forms, and in this increasingly complex world of health care, understanding these applications has become a critical component of your business.

In this article, Robert A. Dowling, MD, describes what urologists need to know about the Quality category of MIPS and nuances of the scoring methodology.

"Determining what to invest in should be based primarily on the needs, temperament, and available resources of each individual or family," write Jeff Witz, CFP, and David Zemon.

In this "Coding Q&A," the Painters also answer a question regarding coding for sling and cystocele repair with mesh repair.

Other pipeline developments include efficacy results for a bladder and prostate cancer drug, an infertility tool to predict sperm quality, the initiation of an immunotherapy combination for mUC, and more.

The provision of health care via technology and without direct eye-to-eye and skin-to-skin contact is an area of growing interest in the U.S. It is also an area of great concern. One of the key conundrums surrounding telemedicine is the when, how, and what to pay for the service.

Value-based payment models tend to fall into three general categories: shared savings programs, capitation models, and episode-of-care models. In this article, Robert A. Dowling, MD, reviews the current landscape of these payment models, including public and private-sector models that may serve as examples for urology.

With the U.S. stock market reaching record highs, it’s important to know how to prepare for an eventual fall. Plus, tax credits may be available for tuition payers.

Neil Baum, MD, and Randy Bauman discuss their tips to making the transition from practice seller to buyer as seamless as possible to keep patient retention rates high.

When trying to determine how much is enough when saving for retirement, there are many elements that must be considered. Plus, weigh these pros and cons when deciding how long to receive payments from an immediate annuity.

Urology-related FDA approvals from 2016 encompassed drugs and devices for prostate cancer, renal cell carcinoma, bladder cancer, stone disease, and more.